Osaka

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• COPD1 trial
• Type 1 diabetes1 trial
• Type 2 diabetes1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Sanofi2 trials

Running trials

• Recruiting

  Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  NCT07190209· Phase 3· Sanofi· Source

• Active, not recruiting

  Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes

  NCT06791291· Phase 2· Sanofi· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• COPD1 recruiting